Product
IAP0971
3 clinical trials
2 indications
Indication
Bladder CancerIndication
Advanced Malignant TumorsClinical trial
A Phase I/II Clincal Trial of Intravesical IAP0971 in Combination With Bacillus Calmette Guerin (BCG) in Patients With BCG Unresponsive High Risk Non-Muscular Invasive Bladder Cancer (NMIBC)Status: Not yet recruiting, Estimated PCD: 2024-10-07
Clinical trial
A Clinical Trial of Phase Ib/II to Evaluate Effect of IAP0971 in Patients With Advanced Malignant TumorsStatus: Recruiting, Estimated PCD: 2026-03-01
Clinical trial
A Phase I/IIa Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of IAP0971 in Patients With Advanced Malignant TumorsStatus: Recruiting, Estimated PCD: 2024-05-30